Nexalin Technology, Inc. (NXL) - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Nexalin Technology, Inc., a Delaware corporation headquartered in Houston, Texas, on May 5, 2025. The report details a material amendment to an existing equity distribution agreement entered into on April 29, 2025.
Key Financial Metrics
The filing does not provide specific revenue, profit, cash flow, margin, or debt figures. The primary financial metric disclosed relates to the capital raising capacity under the "at-the-market" (ATM) offering program:
- Revised Aggregate Offering Price: Up to $3,100,000.
- Previous Aggregate Offering Price: $9,777,825.
- Available for Sale: Approximately $3,100,000 as of May 5, 2025.
Material Changes
On May 5, 2025, the Company executed Amendment No. 1 to its Equity Distribution Agreement with Maxim Group LLC. The material change involves a significant reduction in the maximum amount of common stock shares that may be issued and sold through the ATM Program. The aggregate offering price was reduced from $9,777,825 to $3,100,000.
Outlook, Risks, and Management Commentary
The Company maintains the ATM Program to sell shares of common stock from time to time through Maxim Group LLC as the exclusive sales agent. The amendment was executed in connection with the Company's effective shelf registration statement on Form S-3 (File No. 333-286711). The filing includes a standard disclaimer that the report does not constitute an offer to sell securities in jurisdictions where such an offer would be unlawful. No specific forward-looking guidance or risk factors beyond standard legal disclaimers are detailed in this specific 8-K text.
Key Facts for Investor Verification
- Verify the exact number of shares remaining available for sale under the reduced $3,100,000 cap.
- Review the full text of Amendment No. 1 (Exhibit 10.1) for any changes to commission rates or termination clauses.
- Confirm the status of the Form S-3 shelf registration statement (File No. 333-286711).
- Check subsequent filings for any actual sales executed under the amended ATM Program.